Summary of clinical characteristics (n=33)
| Age of onset (mean) | Latency (mean) | Site of onset (% of cases) | Lesion site (% of cases) | |
|---|---|---|---|---|
| Poststroke | 2–69 y (40.5) | 3 months–3 y (9.5 months) | Arms: 5/10 (50) | 5 basal ganglia (55) |
| (n=10) | Legs: 2/10 (20) | 3 thalamus (33) | ||
| Both: 3/10 (30) | 3 cortical (33) | |||
| Post-trauma | 5–39 y (16.4 y) | 2 weeks–10 y (27.5 months) | Arms: 5/8 (62.5) | 2 basal ganglia (50) |
| (n=8) | Both: 3/8 (37.5) | 1 cortical (25) | ||
| 1 subcortical | ||||
| 1 midbrain (25) | ||||
| Perinatal | 1–17 y (9.7 y) | 1–17 y (9.7 y) | Arms: 3/9 (33) | 3 basal ganglia (42) |
| (n=9) | Legs: 3/9 (33) | 1 thalamus (14.3) | ||
| Both: 3/9 (11) | 2 cortical (28) | |||
| 1 cerebellum/pons (14.3) | ||||
| Miscellaneous | 5 months–16 y (6.3 y) | 1–9 months (4.5 months) | Arms: 3/6 (50) | 2 basal ganglia (40) |
| (n=6) | Legs: 1/6 (16.6) | 3 thalamus (60) | ||
| Both: 2/6 (33) | 2 cortical (40) |